Drug Trial Radar · NCT07213674
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Last checked: Nov 19, 2026Latest source record: Oct 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
750
Planned (sponsor's estimate)
Start
Nov 28, 2025
Primary completion
Jan 7, 2030
Study completion Aug 30, 2032
Sponsor
- Lead sponsor
- AmgenAmgen (AMGN)
- Sponsor type
- Industry
- First posted
- Oct 9, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Male only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study is to compare overall survival (OS) in participants receiving xaluritamig plus abiraterone against investigator's choice (docetaxel, cabazitaxel, or abiraterone).
Conditions
- Metastatic Castration-resistant Prostate Cancer
Interventions
XaluritamigDrug
Xaluritamig will be administered IV.
Abiraterone acetateDrug
Abiraterone acetate will be administered orally.
DocetaxelDrug
Docetaxel will be administered IV.
CabazitaxelDrug
Cabazitaxel will be administered IV.
Primary outcomes
What the sponsor says the trial is designed to measure.
- OSTime frame: Up to approximately 51 months
Locations
159 sites in 18 countries. Site status is shown where the registry gives one.
City of Hope Cancer Center Phoenix
Goodyear, Arizona · Recruiting
University of Arizona Cancer Center
Tucson, Arizona · Recruiting
City of Hope National Medical Center
Duarte, California · Recruiting
City of Hope Orange County Lennar Foundation Cancer Center
Duarte, California · Recruiting
Providence Saint Jude Medical Center
Fullerton, California · Recruiting
University of California Los Angeles
Los Angeles, California · Recruiting
University of California Irvine
Orange, California · Recruiting
University of California San Francisco
San Francisco, California · Recruiting
Providence Saint Johns Health Center
Santa Monica, California · Recruiting
Rocky Mountain Cancer Centers
Denver, Colorado · Recruiting
Hartford HealthCare Cancer Institute at Hartford Hospital
Hartford, Connecticut · Recruiting
Medical Oncology Hematology Consultants Helen F Graham Cancer Center
Newark, Delaware · Recruiting
Moffitt Cancer Center
Tampa, Florida · Recruiting
City of Hope Atlanta
Newnan, Georgia · Recruiting
University of Illinois Chicago
Chicago, Illinois · Recruiting
Cancer Care Specialists of Illinois
Decatur, Illinois · Recruiting
Midwestern Regional Medical Center dba City of Hope Chicago
Zion, Illinois · Recruiting
University of Kansas Medical Center
Westwood, Kansas · Recruiting
University of Louisville Health - James Graham Brown Cancer Center
Louisville, Kentucky · Recruiting
Norton Cancer Institute
Louisville, Kentucky · Terminated
University of Maryland Greenebaum Cancer Center
Baltimore, Maryland · Recruiting
Johns Hopkins Hospital Sidney Kimmell Comprehensive Cancer Center
Baltimore, Maryland · Recruiting
Barbara Ann Karmanos Cancer Institute
Lansing, Michigan · Recruiting
Minnesota Oncology Hematology PA
Minneapolis, Minnesota · Recruiting
University of Minnesota Medical Center Fairview
Minneapolis, Minnesota · Recruiting
Hematology Oncology Association of Central New York
East Syracuse, New York · Recruiting
Memorial Sloan Kettering Cancer Center
New York, New York · Recruiting
Oncology Hematology Care Incorporated
Cincinnati, Ohio · Recruiting
The Ohio State University
Columbus, Ohio · Recruiting
Dayton Physicians LLC Dayton
Dayton, Ohio · Recruiting
Hightower Clinical
Oklahoma City, Oklahoma · Recruiting
Oregon Oncology Specialists
Salem, Oregon · Recruiting
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania · Recruiting
South Texas Accelerated Research Therapeutics - Carolinas
Myrtle Beach, South Carolina · Recruiting
Sarah Cannon Research Institute Oncology Partners
Nashville, Tennessee · Recruiting
United States Oncology Regulatory Affairs Corporate Office
Nashville, Tennessee · Recruiting
The Center for Cancer and Blood Disorders
Arlington, Texas · Recruiting
University of Texas Southwestern Medical Center
Dallas, Texas · Recruiting
Renovatio Clinical
Houston, Texas · Recruiting
Texas Oncology - Northeast Texas
Tyler, Texas · Recruiting
Showing 40 of 159 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.